Skip to main content
TipRanks
Go Ultimate75% OFF

Vivos Therapeutics (VVOS) Stock Forecast & Price Target

248 Followers
See the Price Targets and Ratings of:

VVOS Analyst Ratings

Currently, no data available

VVOS Stock 12 Month Forecast

There Are No Analyst Ratings for VVOS In The Last 3 Months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for VVOS
Price TargetArticle
Alliance Global Partners$1.75→$0.75hold733.33%UpsideReiterated07/08/26
Ascendiant$3→$3.10buy3344.44%UpsideReiterated06/04/26
H.C. Wainwright$2.50buy2677.78%UpsideReiterated04/17/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
MDWDMediwound
IMUXImmunic
OVIDOvid Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Vivos Therapeutics

3 Months
Lucas Ward
Lucas WardAscendiant
Success Rate5/12 ratings generated profit
42%
Average Return
+2.39%

Copying Lucas Ward's trades and holding each position for 3 Months would result in 41.67% of your transactions generating a profit, with an average return of +2.39% per trade.

1 Year
Lucas Ward
Lucas WardAscendiant
Success Rate1/12 ratings generated profit
8%
Average Return
-50.26%

Copying Lucas Ward's trades and holding each position for 1 Year would result in 8.33% of your transactions generating a profit, with an average return of -50.26% per trade.

2 Years
Lucas Ward
Lucas WardAscendiant
Success Rate0/12 ratings generated profit
0%
Average Return
-81.50%

Copying Lucas Ward's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -81.50% per trade.

VVOS Analyst Recommendation Trends

01234Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for VVOS
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy11000
Buy00000
Hold11100
Sell00000
Strong Sell00000
total22100

In the current month, VVOS has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. VVOS average Analyst price target in the past 3 months is ―.

VVOS Financial Forecast

$-2$-1.5$-1$-0.5$0Q3 2025Q2 2026Q3 2026
High$-0.30
Consensus$-0.30
Low$-0.30

VVOS Earnings Forecast

Next quarter’s earnings estimate for VVOS is -$0.30 with a range of -$0.30 to -$0.30. The previous quarter’s EPS was -$0.31. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$3.8M$4.6M$5.3M$6M$6.8MQ3 2025Q2 2026Q3 2026
High$5.47M
Consensus$5.47M
Low$5.47M

VVOS Sales Forecast

Next quarter’s sales forecast for VVOS is $5.47M with a range of $5.47M to $5.47M. The previous quarter’s sales results were $5.15M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

VVOS Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Vivos Therapeutics?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of VVOS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.